OBJECTIVE: Discussion of lung function changes in patients with allergic rhinitis and its clinical significance. METHOD: Using UNICAP100 allergen detector testing 64 patients of allergic rhinitis without asthma symptoms, testing the value of serum total IgE and using immunofluorescence methods for testing inhalation allergen, simultaneously checking the pulmonary function and bronchial provocation. Checking the lung function of 64 patients with non-symptoms of allergic rhinitis in other departments (control group), lung function were compared into two groups of patients. RESULT: In the allergic rhinitis group, 37 patients had abnormal lung function (57.81%), 8 cases in them had obstructive pulmonary ventilation, 12 cases had small airway dysfunction, 31 cases had increased airway resistance respectively. In the control group 15 patients (23.44%) had pulmonary function abnormalities, 2 cases had obstructive pulmonary ventilation, 4 cases had small airway dysfunction, 11 cases had increased airway resistance respectively. Changes in lung function compared in the two groups was statistically significant (P < 0.05). Allergic rhinitis patients with abnormal lung function bronchial provocation test positive rate was significantly higher than the normal lung function in patients with allergic rhinitis, there had statistically significant difference between the two groups (P < 0.05). CONCLUSION After checking the lung function of non-asthmatic symptom patients with allergic rhinitis, we could find abnormal lung function patients of allergic rhinitis and do bronchial provocation test in them, there has important clinical significance of early detection and treatment the patients of allergic rhinitis with bronchial asthma.
Adult ; Bronchial Hyperreactivity ; physiopathology ; Case-Control Studies ; Female ; Humans ; Male ; Nasal Septum ; abnormalities ; Peak Expiratory Flow Rate ; Respiratory Function Tests ; Rhinitis, Allergic, Perennial ; physiopathology

OBJECTIVE To comprehensively evaluate four weekly preparations of glucagon-like peptide-1 receptor agonist （GLP-1RA） marketed in China，and to provide evidence for hospitals to optimize drug catalogs and clinical rational drug use. METHODS Mini health technology assessment method was used to establish detailed evaluation rules according to A Quick Guideline for Drug Evaluation and Selection in Chinese Medical Institutions， and conduct comprehensive evaluation of four GLP- 1RA weekly preparations from aspects of pharmaceutical characteristics， effectiveness， safety， economy and other attributes. RESULTS Mini health technology assessment scores of the four GLP-1RA weekly preparations from high to low were dulaglutide 78.60 points， semaglutide 77.35 points，polyethylene glycol loxenatide 67.40 points， and exenatide microspheres 65.50 points， respectively. Dulaglutide had advantages in reducing blood sugar， arteriosclerotic cardiovascular disease， kidney benefits， and cost- effectiveness. Semaglutide had advantages in reducing blood sugar and weight loss， but its cost-effectiveness was lower than that of dulaglutide. Exenatide microspheres had advantages in the use of children， but its daily average treatment cost is the highest. Polyethylene glycol loxenatide needed further clinical evidence. CONCLUSIONS Four GLP-1RA weekly preparations all have high pharmaceutical comprehensive scores. Dulaglutide and semaglutide may have more comprehensive pharmaceutical value among them， while the use of exenatide microspheres for children is unique.